Proton therapy for pediatric head and neck malignancies
Pediatric Blood & Cancer2017Vol. 65(2)
Citations Over TimeTop 10% of 2017 papers
Jennifer Vogel, Stefan Both, Maura Kirk, Hann‐Hsiang Chao, Rochelle Bagatell, Yimei Li, Richard B. Womer, Naomi Balamuth, Anne F. Reilly, Goldie Kurtz, Robert A. Lustig, Zelig Tochner, Christine E. Hill‐Kayser
Abstract
In this study, we report low rates of acute toxicity in a cohort of pediatric patients with head and neck malignancies. PBT appears safe for this patient population, with local control rates similar to historical reports. Longer follow-up will be required to evaluate late toxicity and long-term disease control.
Related Papers
- → Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma(1976)96 cited
- → Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck(1985)48 cited
- → The Efficacy of Orgotein in the Treatment of Acute Toxicity Due to Radiotherapy on Head and Neck Tumors(2002)22 cited
- Comparison and analysis between the toxicity of radiotherapy for newly diagnosed Nasopharygeal Carcinoma and conventional IMRT technique(2007)
- Comparison of toxicity of radiotherapy between conventional and intensity-modulated radiation therapy technique for newly diagnosed nasopharygeal carcinoma(2011)